Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction

BACKGROUND: The aim of this study was to evaluate the effect of levosimendan on mortality in cardiogenic shock (CS) after ST elevation myocardial infarction (STEMI). METHODS AND RESULTS: Data were obtained prospectively from the SCAAR (Swedish Coronary Angiography and Angioplasty Register) and the R...

Descripción completa

Detalles Bibliográficos
Autores principales: Omerovic, Elmir, Råmunddal, Truls, Albertsson, Per, Holmberg, Mikael, Hallgren, Per, Boren, Jan, Grip, Lars, Matejka, Göran
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941779/
https://www.ncbi.nlm.nih.gov/pubmed/20859537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941779/
https://www.ncbi.nlm.nih.gov/pubmed/20859537

Ejemplares similares